IMM 6.85% 39.0¢ immutep limited

boiler, it's hardly fda imposed (i.e. fda making them call it a...

  1. 244 Posts.
    boiler, it's hardly fda imposed (i.e. fda making them call it a phase 2 trial).

    it is just an issue with having to classify a trial as phase 2/3 due to website design

    be careful with how you word things. i have no issue with you finding that it was changed to a phase 2 trial, but do not promote it as such without proof.

    now that we have confirmation that in fact nothing has changed, it would be nice to see you accept this as fact, and retract your statement that

    "Therefore no clinical error, and the information the site contains is FDA imposed."

    also, you line: "We have had interim data and now we are a Phase 2 ???????" is implying that after interim data, the fda has imposed CANVAS to be a phase II. while you are not directly saying this, one can only assume it from the way you have posted. again, for the sake of being impartial, you should acknowledge that this is not true.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
39.0¢
Change
0.025(6.85%)
Mkt cap ! $551.9M
Open High Low Value Volume
37.0¢ 39.0¢ 36.8¢ $1.005M 2.632M

Buyers (Bids)

No. Vol. Price($)
9 20853 39.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 353568 14
View Market Depth
Last trade - 13.42pm 30/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.